Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-03 4:41 pm Purchase |
2023-07-25 | 13D | Turnstone Biologics Corp. TSBX |
Versant Venture Capital V L.P. | 2,899,216 12.500% |
2,899,216 (New Position) |
Filing History |
| 2023-02-09 4:30 pm Unchanged |
2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Versant Venture Capital V L.P. | 2,895,695 3.500% |
0 (Unchanged) |
Filing History |
| 2023-01-06 4:19 pm Sale |
2022-12-29 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 2,094,451 5.000% |
-250,000 (-10.66%) |
Filing History |
| 2022-06-13 4:38 pm Sale |
2022-06-03 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 2,344,451 5.600% |
-250,000 (-9.64%) |
Filing History |
| 2022-02-10 8:21 pm Sale |
2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Versant Venture Capital V L.P. | 382,961 0.800% |
-1,512,041 (-79.79%) |
Filing History |
| 2022-02-10 7:58 pm Unchanged |
2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Versant Venture Capital V L.P. | 2,895,695 4.300% |
0 (Unchanged) |
Filing History |
| 2021-08-16 4:57 pm Unchanged |
2021-08-05 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 2,594,451 7.000% |
0 (Unchanged) |
Filing History |
| 2021-04-19 6:05 pm Purchase |
2021-04-08 | 13D | VectivBio Holding AG VECT |
Versant Venture Capital V L.P. | 2,791,748 8.200% |
2,791,748 (New Position) |
Filing History |
| 2021-02-26 4:36 pm Sale |
2021-02-16 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 2,594,451 7.100% |
-550,000 (-17.49%) |
Filing History |
| 2021-02-16 07:30 am Unchanged |
2020-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Versant Venture Capital V L.P. | 2,895,695 6.100% |
0 (Unchanged) |
Filing History |
| 2021-02-12 8:27 pm Sale |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Versant Venture Capital V L.P. | 1,895,002 5.800% |
-789,560 (-29.41%) |
Filing History |
| 2021-01-25 4:27 pm Sale |
2021-01-14 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 3,144,451 8.600% |
-275,000 (-8.04%) |
Filing History |
| 2020-07-06 9:31 pm Purchase |
2020-06-23 | 13D | Repare Therapeutics Inc. RPTX |
Versant Venture Capital V L.P. | 3,419,451 9.300% |
3,419,451 (New Position) |
Filing History |